Modulatory effects of naringin on hepatic key enzymes of carbohydrate metabolism in high-fat diet/low-dose streptozotocin-induced diabetes in rats

General Physiology and Biophysics

Volumn 36, Issue 3, 2017, Pages 343-352

  Pari, Leelavinothan ^a   Chandramohan, Ramasamy ^a  

^a ANNAMALAI UNIVERSITY   (India)

Author keywords

Carbohydrate metabolism; Glucose; High fat diet; Insulin; Naringin; Streptozotocin

Indexed keywords

AURANTIIN; FRUCTOSE BISPHOSPHATASE; GLUCOSE; GLUCOSE 6 PHOSPHATASE; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; GLYCOGEN; GLYCOGEN PHOSPHORYLASE; GLYCOGEN SYNTHASE; GLYCOSYLATED HEMOGLOBIN; HEXOKINASE; LIVER ENZYME; ANTIDIABETIC AGENT; FLAVANONE DERIVATIVE; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIDIABETIC ACTIVITY; ARTICLE; CARBOHYDRATE METABOLISM; CONTROLLED STUDY; DIABETES MELLITUS; DOSE RESPONSE; DRUG EFFECT; ENZYME ACTIVITY; GLUCOSE BLOOD LEVEL; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LIPID DIET; MALE; NONHUMAN; PANCREAS; RAT; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; ANIMAL; DIABETES MELLITUS, EXPERIMENTAL; DRUG EFFECTS; ENZYMOLOGY; LIVER; METABOLISM; WISTAR RAT;

ANIMALS; CARBOHYDRATE METABOLISM; DIABETES MELLITUS, EXPERIMENTAL; DIET, HIGH-FAT; DOSE-RESPONSE RELATIONSHIP, DRUG; FLAVANONES; HYPOGLYCEMIC AGENTS; LIVER; MALE; RATS; RATS, WISTAR; STREPTOZOCIN;

EID: 85020629504     PISSN: 02315882     EISSN: 13384325     Source Type: Journal    
DOI: 10.4149/gpb_2016055     Document Type: Article

References (42)

1. American Diabetes Association (2011): Diagnosis and classification of diabetes mellitus. Diabetes Care 34, 62-69 https://doi.org/10.2337/dc11-S062
2. Brandstrup N., Kirk J. E., Bruni C. (1957): Determination of glucokinase in tissues. J. Gerontol. 12, 166-171 https://doi.org/10.1093/geronj/12.2.166
3. Cappai G., Songini M., Doria A., Cavallerano J. D., Lorenzi M. (2011): Increased prevalence of proliferative retinopathy in patients with type 1 diabetes who are deficient in glucose-6-phosphate dehydrogenase. Diabetologia 54, 1539-1542 https://doi.org/10.1007/s00125-011-2099-3
4. Chandramohan R., Pari L., Rathinam A., Sheikh B. A. (2015): Tyrosol, a phenolic compound, ameliorates hyperglycemia by regulating key enzymes of carbohydrate metabolism in streptozotocin induced diabetic rats. Chem. Biol. Interact. 229, 44-54 https://doi.org/10.1016/j.cbi.2015.01.026
5. Chanet A., Milenkovic D., Deval C., Potier M., Constans J., Mazur A. (2012): Naringin, the major grapefruitflavonoid, specifically affects atherosclerosis development in diet-induced hypercholesterolemia in mice. J. Nutr. Biochem. 23, 469-477 https://doi.org/10.1016/j.jnutbio.2011.02.001
6. Du Vigneaud V., Karr W. G. (1925): Carbohydrates utilization rate of disappearance of D-glucose from the blood. J. Biol. Chem. 66, 281-300
7. Ells H. A., Kirkman H. N. (1961): A colorimetric method for assay of erythrocytic glucose-6-phosphate dehydrogenase. Proc. Soc. Exp. Biol. Med. 106, 607-609 https://doi.org/10.3181/00379727-106-26418
8. Fiske C. H., Subbarow J. (1925): The colorimetric determination of phosphorous. J. Biol. Chem. 66, 375-400
9. Franconi F., Seghieri G., Canu S., Straface E., Campesi I., Malorni W. (2008): Are the available experimental models of type 2 diabetes appropriate for a gender perspective? Pharmacol. Res. 57, 6-18 https://doi.org/10.1016/j.phrs.2007.11.007
10. Gancedo J. M., Gancedo C. (1971): Fructose-1,6-diphosphatase, phosphofructokinase and glucose-6-phosphate dehydrogenase from fermenting and non fermenting yeasts. Arch. Mikrobiol. 76, 132-138 https://doi.org/10.1007/BF00411787
11. Golden S., Wals P. A., Katz J. (1977): An improved procedure for the assay of glycogen synthase and phosphorylase in rat liver homogenates. Anal. Biochem. 77, 436-445 https://doi.org/10.1016/0003-2697(77)90257-3
12. Golechha M., Chaudhry U., Bhatia J., Saluja D., Arya D. S. (2011): Naringin protects against kainic acid-induced status epilepticus in rats: evidence for an antioxidant, anti-inflammatory and neuroprotective intervention. Biol. Pharm. Bull. 34, 360-365 https://doi.org/10.1248/bpb.34.360
13. He L., Sabet A., Djedjos S., Miller R., Sun X., Hussain M. A., Radovick S., Wondisford F. E. (2009): Metformin and insulin suppress hepatic gluconeogenesis through phosphorylation of CREB binding protein. Cell 137, 635-646 https://doi.org/10.1016/j.cell.2009.03.016
14. Jeon S. M., Bok S. H., Jang M. K., Lee M. K., Nam K. T., Park Y. B., Rhee S. J., Choi M. S. (2001): Antioxidative activity of naringin and lovastatin in high cholesterol-fed rabbits. Life Sci. 69, 2855-2866 https://doi.org/10.1016/S0024-3205(01)01363-7
15. Jian L. J. Q., Joyce T., Christina K. H., Cynthia S., Richard H., Gerald M. R. (1998): Nongenetic mouse models of non-insulin dependent diabetes mellitus. Metabolism 47, 663-668 https://doi.org/10.1016/S0026-0495(98)90027-0
16. Jung U. J., Lee M. K., Jeong K. S., Choi M. S. (2004): The hypoglycemic effects of hesperidin and naringin are partly mediated by hepatic glucose-regulating enzymes in C57BL/KsJ-db/db mice. J. Nutr. 134, 2499-2503
17. Kaneto H., Kajimoto Y., Fujitani Y., Matsuoka T., Sakamoto K., Matsuhisa M., Yamasaki Y., Hori M. (1999): Oxidative stress induces p21 expression in pancreatic islet cells: possible implication in beta-cell dysfunction. Diabetologia 42, 1093-1097 https://doi.org/10.1007/s001250051276
18. Kaneto H., Xu G., Song K. H., Suxuma K., Bonner-Weir S., Sharma A., Weir, G. C. (2001): Activation of the hexosamine pathway leads to deterioration of pancreatic β-cell function through the induction of oxidative stress. J. Biol. Chem. 276, 31099-31104 https://doi.org/10.1074/jbc.m104115200
19. Kasetti R. B., Rajasekhar M. D., Kondeti V. K., Fatima S. S., Kumar E. G., Swapna S. (2010): Antihyperglycemic and antihyperlipidemic activities of methanol: water (4:1) fraction isolated from aqueous extract of Syzygium alternifolium seeds in streptozotocin induced diabetic rats. Food Chem. Toxicol. 48, 1078-1084 https://doi.org/10.1016/j.fct.2010.01.029
20. Koide H., Oda T. (1959): Pathological occurrence of glucose-6-phosphatase in serum in liver diseases. Clin. Chim. Acta 4, 554-561 https://doi.org/10.1016/0009-8981(59)90165-2
21. Liu Z., Li W., Li X., Zhang M., Chen L., Zheng Y., Sun G., Ruan C. (2013): Antidiabetic effects of malonyl ginsenosides from Panax ginsengon type 2 diabetic rats induced by high-fat diet and streptozotocin. J. Ethnopharmacol. 145, 233-240 https://doi.org/10.1016/j.jep.2012.10.058
22. Lowry O. H., Rosebrough N. J., Farr A. L., Randall R. J. (1951): Protein measurement with the Folin phenol reagent, J. Biol. Chem. 193, 265-275
23. Mahmoud A. M., Ashour M. B., Abdel-Moneim A., Ahmed O. M. (2012): Hesperidin and naringin attenuate hyperglycemia-mediated oxidative stress and proinflammatory cytokine production in high fat fed/streptozotocin-induced type 2 diabetic rats. J. Diabetes Complicat. 26, 483-490 https://doi.org/10.1016/j.jdiacomp.2012.06.001
24. McAnuff M. A., Omoruyi F. O., Morrison E. Y., Asemota H. N. (2005): Changes in some liver enzymes in streptozotocin-induced diabetic rats fed sapogenin extract from bitter yam (Dioscorea polygonoides) or commercial diosgenin. West Indian Med. J. 54, 97-101 https://doi.org/10.1590/s0043-31442005000200002
25. Mirmiran P., Bahadoran Z., Azizi F. (2014): Functional foods-based diet as a novel dietary approach for management of type 2 diabetes and its complications: a review. World J. Diabetes 5, 267-281 https://doi.org/10.4239/wjd.v5.i3.267
26. Morales M. A., Jabbagy A. J., Terenizi H. R. (1973): Mutations affecting accumulation of glycogen. Neurospora Newsletter 20, 24-25 https://doi.org/10.4148/1941-4765.1830
27. Prabhakar P. K., Prasad R., Ali S., Doble M. (2013): Synergistic interaction of ferulic acid with commercial hypoglycemic drugs in streptozotocin induced diabetic rats. Phytomedicine 20, 488-494 https://doi.org/10.1016/j.phymed.2012.12.004
28. Prasath G. S., Subramanian S.P. (2011): Modulatory effects of fisetin, a bioflavonoid, on hyperglycemia by attenuating the key enzymes of carbohydrate metabolism in hepatic and renal tissues in streptozotocin-induced diabetic rats. Eur. J. Pharmacol. 668, 492-496 https://doi.org/10.1016/j.ejphar.2011.07.021
29. Sahin, K., Onderci M., Tuzcu M. (2007): Effect of chromium on carbohydrate and lipid metabolism in a rat model of type 2 diabetes mellitus: the fat-fed, streptozotocin-treated rat. Metab. Clin. Exp. 56, 1233-1240 https://doi.org/10.1016/j.metabol.2007.04.021
30. Salas-Salvado J., Martinez-González M. A., Bullo M., Ros E. (2011): The role of diet in the prevention of type 2 diabetes. Nutr. Metab. Cardiovasc. Dis. 21, 32-48 https://doi.org/10.1016/j.numecd.2011.03.009
31. Sharma A. K., Bharti S., Ojha S., Bhatia J., Kumar N., Ray R., Kumari S., Arya D. S. (2011): Up-regulation of PPARγ, heat shock protein-27 and -72 by naringin attenuates insulin resistance, β-cell dysfunction, hepatic steatosis and kidney damage in a rat model of type 2 diabetes. Br. J. Nutr. 106, 1713-1723 https://doi.org/10.1017/S000711451100225X
32. Shull K. H., Ashmore J., Mayer J. (1956): Hexokinase, glucose-6-phosphatase and phosphorylase levels in hereditarily obese-hyperglycemic mice. Arch. Biochem. Biophys. 62, 210-216 https://doi.org/10.1016/0003-9861(56)90104-7
33. Skovsø S. (2014): Modeling type 2 diabetes in rats using high fat diet and streptozotocin. J. Diabetes Investig. 5, 349-358 https://doi.org/10.1111/jdi.12235
34. Srinivasan S., Sathish G., Jayanthi M., Muthukumaran J., Muruganathan U., Ramachandran V. (2014): Ameliorating effect of eugenol on hyperglycemia by attenuating the key enzymes of glucose metabolism in streptozotocin-induced diabetic rats. Mol. Cell. Biochem. 385, 159-168 https://doi.org/10.1007/s11010-013-1824-2
35. Sundaram R., Naresha R., Shanthi P., Sachdanandam P. (2013): Modulatory effect of green tea extract on hepatic key enzymes of glucose metabolism in streptozotocin and high fat diet induced diabetic rats. Phytomedicine 20, 577-584 https://doi.org/10.1016/j.phymed.2013.01.006
36. Tapas A. R., Sakarkar D. M., Kakde R. B. (2008): Flavonoids as nutraceuticals: A review. Trop. J. Pharm. Res. 7, 1089-1099 https://doi.org/10.4314/tjpr.v7i3.14693
37. Tiedge M., Richter T., Lenzen S. (2000): Importance of cysteine residues for the stability and catalytic activity of human pancreatic beta cell glucokinase. Arch. Biochem. Biophys. 375, 251-260 https://doi.org/10.1006/abbi.1999.1666
38. Trinder P. (1969): Determination of glucose in blood using glucose oxidase with an alternative oxygen acceptor. Ann. Clin. Biochem. 6, 24-27 https://doi.org/10.1177/000456326900600108
39. Unger R. H., Clark G. O., Scherer P. E., Orci L. (2010): Lipid homeostasis, lipotoxicity and the metabolic syndrome. Biochim. Biophys. Acta 1801, 209-214 https://doi.org/10.1016/j.bbalip.2009.10.006
40. Vats V., Yadav S. P., Grover J. K. (2003): Effect of Trigonella foenum graecumon glycogen content of tissues and the key enzymes of carbohydrate metabolism. J. Ethnopharmacol. 85, 237-242 https://doi.org/10.1016/S0378-8741(03)00022-9
41. Verma N., Amresh G., Sahu P. K., Mishra N., Ch Rao V., Singh A. P. (2013): Pharmacological evaluation of hyperin for antihyperglycemic activity and effect on lipid profile in diabetic rats. Indian J. Exp. Biol. 51, 65-72
42. Zbarsky V., Datla K. P., Parkar S., Rai D. K., Aruoma O. I., Dexter D. T. (2005): Neuroprotective properties of the natural phenolic antioxidants curcumin and naringenin but not quercetin and fisetin in a 6-OHDA model of Parkinson's disease. Free Radic. Res. 39, 1119-1125 https://doi.org/10.1080/10715760500233113